Table 4.
Parameter | |||
---|---|---|---|
Groups | GPx (mU/100 mg tissue) | GST (mU/100 mg tissue) | SOD (mU/100 mg tissue) |
Normal control | 101.91 ± 8.61 | 105.40 ± 4.72 | 112.91 ± 1.68 |
DXR-injected control group | 70.10 ± 2.32++ | 69.03 ± 4.63++ | 111.29 ± 1.35 |
DXR-injected group supplemented with rutin | 85.28 ± 5.29∗ | 79.98 ± 5.24$ | 137.89 ± 2.63∗∗$$ |
DXR-injected group supplemented with quercetin | 75.60 ± 5.30 | 99.10 ± 14.26∗ | 126.74 ± 4.77∗∗ |
DXR-injected group supplemented with rutin and quercetin | 79.56 ± 1.51 | 108.72 ± 6.64∗ | 123.51 ± 3.35∗∗ |
F-probability | P < 0.001 | P < 0.01 | P < 0.001 |
Values are M ± SE (n = 6). +P < 0.05, ++P < 0.01: the DXR-injected control group vs. normal control. ∗P < 0.05, ∗∗P < 0.01: the DXR-injected groups treated with rutin and/or quercetin vs. DXR-injected control group. $P < 0.05, $$P < 0.01: the DXR-injected groups treated with rutin or quercetin alone vs. DXR-injected group treated with rutin and quercetin mixture.